
Medicine and Health
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Atezolizumab Post Chemo-Radiation
L. J. Saade and A. Tfayli
This study reveals a significant risk of pneumonitis in stage III NSCLC patients receiving Atezolizumab following chemoradiation, with 8 out of 14 patients affected. Conducted by Lili Jose Saade and Arafat Tfayli, the findings raise concerns about treatment implications and the need for larger studies.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.